Cookies show us what works. Privacy
Cookies show us what works. Privacy
Pfizer (PFE) is expected to report earnings for the quarter ending Dec 31, 2026 on Tuesday, Feb 2, 2027. Analysts expect earnings per share of $0.69 (18 analysts) on revenue of $17.2B.
Last report, Nov 3, 2026: EPS $0.87 against $0.72 expected (+20.8%). The stock moved +2.6% the next day. Beat the EPS estimate in 8 of the last 8 reports. The stock moved 2.2% on average the next day, up or down; the largest move was +3.9%.
| Reported | Quarter ended | EPS | Estimate | Surprise | Next day |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 27, 2026 | $0.87 | $0.72 | +20.8% | +2.6% |
| Aug 4, 2026 | Jun 28, 2026 | $0.77 | $0.68 | +13.2% | +1.6% |
| May 5, 2026 | Mar 29, 2026 | $0.75 | $0.72 | +4.2% | +0.3% |
| Feb 3, 2026 | Dec 31, 2025 | $0.66 | $0.57 | +15.8% | +3.9% |
| Nov 4, 2025 | Sep 28, 2025 | $0.87 | $0.63 | +38.1% | +1.3% |
| Aug 5, 2025 | Jun 29, 2025 | $0.78 | $0.57 | +36.8% | -3.3% |
| Apr 29, 2025 | Mar 30, 2025 | $0.92 | $0.67 | +37.3% | +2.6% |
| Feb 4, 2025 | Dec 31, 2024 | $0.63 | $0.46 | +37.0% | +2.2% |
Pfizer (PFE) is expected to report earnings for the quarter ending Dec 31, 2026 on Tuesday, Feb 2, 2027.
$0.69 a share, the average of 18 analysts, for the quarter ending Dec 31, 2026. The revenue estimate is $17.2B.
Yes. Last report, Nov 3, 2026: EPS $0.87 against $0.72 expected (+20.8%). The stock moved +2.6% the next day.
Report dates come from the Alpha Vantage earnings calendar and stay expected until the company confirms them. EPS is as reported against the analyst average; the next-day move is close to close. Not investment advice.